SI1176976T1 - Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women - Google Patents

Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women

Info

Publication number
SI1176976T1
SI1176976T1 SI200030886T SI200030886T SI1176976T1 SI 1176976 T1 SI1176976 T1 SI 1176976T1 SI 200030886 T SI200030886 T SI 200030886T SI 200030886 T SI200030886 T SI 200030886T SI 1176976 T1 SI1176976 T1 SI 1176976T1
Authority
SI
Slovenia
Prior art keywords
late
mid
administered
treatment
follicular phase
Prior art date
Application number
SI200030886T
Other languages
Slovenian (sl)
Other versions
SI1176976T2 (en
Inventor
Stephen Franks
Stephen Hillier
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1176976(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of SI1176976T1 publication Critical patent/SI1176976T1/en
Publication of SI1176976T2 publication Critical patent/SI1176976T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200030886T 1999-05-07 2000-05-05 Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women SI1176976T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99303574 1999-05-07
EP00927534.8A EP1176976B2 (en) 1999-05-07 2000-05-05 Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women
PCT/GB2000/001745 WO2000067778A1 (en) 1999-05-07 2000-05-05 Gonadotrophins

Publications (2)

Publication Number Publication Date
SI1176976T1 true SI1176976T1 (en) 2006-10-31
SI1176976T2 SI1176976T2 (en) 2015-12-31

Family

ID=8241371

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030886T SI1176976T2 (en) 1999-05-07 2000-05-05 Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women

Country Status (18)

Country Link
US (2) US7695721B1 (en)
EP (1) EP1176976B2 (en)
JP (1) JP4975215B2 (en)
CN (1) CN1352566A (en)
AR (1) AR023869A1 (en)
AT (1) ATE332705T1 (en)
AU (1) AU4592800A (en)
BR (1) BR0010709B1 (en)
CA (1) CA2372714A1 (en)
DE (1) DE60029318T3 (en)
DK (1) DK1176976T4 (en)
ES (1) ES2267531T5 (en)
HK (1) HK1045261A1 (en)
IL (2) IL146252A0 (en)
PT (1) PT1176976E (en)
SI (1) SI1176976T2 (en)
TW (1) TWI242440B (en)
WO (1) WO2000067778A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005504072A (en) * 2001-09-12 2005-02-10 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ Use of LH in superovulation induction
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
RS21004A (en) * 2001-09-12 2006-12-15 Aplied Research Systems Ars Holding N.V. Use of hcg in controlled ovarian hyperstimulation
CN100376289C (en) * 2001-09-12 2008-03-26 应用研究系统Ars股份公司 Use of HCG and LH in controlled ovarian hyperstimulation
CA2515297A1 (en) * 2003-02-07 2004-08-19 Ambros Valentin Huber Use of human chorionic gonadotropin in the treatment of symptoms caused by endometriosis
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
EP1638595B1 (en) * 2003-06-20 2013-03-20 Ares Trading S.A. Freeze-dried fsh / lh formulations
TWI488640B (en) 2008-04-16 2015-06-21 Ferring Int Ct Sa Pharmaceutical preparation
TWI532495B (en) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 Pharmaceutical preparation
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
EP2842567A1 (en) * 2010-09-29 2015-03-04 Ferring B.V. Composition for controlled ovarian stimulation
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
KR20140053991A (en) 2011-07-18 2014-05-08 아츠 바이올로직스 에이/에스 Long acting luteinizing hormone (lh) compound
WO2014013491A1 (en) * 2012-07-18 2014-01-23 Mor Research Applications Ltd. Intrauterine device
WO2018080120A1 (en) * 2016-10-28 2018-05-03 Samsung Electronics Co., Ltd. Method and apparatus for follicular quantification in 3d ultrasound images
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
IT202000022015A1 (en) * 2020-09-18 2022-03-18 Marca Antonio La NEW USE OF LUTEINIZING HORMONE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197570B (en) * 1983-02-11 1988-12-06 Serono Ist Farm MIXTURES OF FSH AND LH FROM PORCINE HYPOPHYSIS IN DEFINED RATIO
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4725579A (en) 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
DK49987A (en) * 1987-01-30 1988-07-31 Nordisk Gentofte PROCEDURE FOR TREATING INFERTILITY AND METHOD FOR USING THE PROCEDURE
US5356876A (en) 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
CA2353085A1 (en) * 1998-12-01 2000-06-08 Akzo Nobel N.V. Improvement of folliculogenesis

Also Published As

Publication number Publication date
AR023869A1 (en) 2002-09-04
TWI242440B (en) 2005-11-01
DK1176976T3 (en) 2006-11-13
ES2267531T3 (en) 2007-03-16
DE60029318T2 (en) 2007-08-09
DE60029318D1 (en) 2006-08-24
CN1352566A (en) 2002-06-05
DE60029318T8 (en) 2007-11-22
US7695721B1 (en) 2010-04-13
DE60029318T3 (en) 2016-03-10
IL146252A (en) 2010-06-30
WO2000067778A1 (en) 2000-11-16
CA2372714A1 (en) 2000-11-16
US7151083B2 (en) 2006-12-19
BR0010709B1 (en) 2011-11-29
EP1176976A1 (en) 2002-02-06
US20040224895A1 (en) 2004-11-11
ES2267531T5 (en) 2015-11-24
AU4592800A (en) 2000-11-21
EP1176976B1 (en) 2006-07-12
EP1176976B2 (en) 2015-10-21
JP4975215B2 (en) 2012-07-11
JP2002544168A (en) 2002-12-24
PT1176976E (en) 2006-11-30
DK1176976T4 (en) 2015-11-02
ATE332705T1 (en) 2006-08-15
HK1045261A1 (en) 2002-11-22
IL146252A0 (en) 2002-07-25
BR0010709A (en) 2002-06-04
SI1176976T2 (en) 2015-12-31

Similar Documents

Publication Publication Date Title
SI1176976T2 (en) Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
HK1045646A1 (en) Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
EE200100480A (en) Xenon for use in the treatment of nerve poisoning
AUPQ302899A0 (en) Implants for the use in the treatment of aneurysmal disease
HK1033278A1 (en) Pharmaceutical preparation for use in anti-asthma therapy.
AU4468201A (en) External preparation for the skin and beautifying agents
IL153708A0 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
HRP20010655B1 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
IL138732A0 (en) The use of polyamines in the treatment of dermatological symptoms
HUP0200441A3 (en) Tetrahydropyran derivatives and their use as therapeutic agents and process for preparation the compounds
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2001268710A1 (en) Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
AU5497000A (en) Non-malignant disease treatment with ras antagonists
IL150212A0 (en) New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
IL147154A (en) Polymorphic salt of eletriptan hemisulphate and its use in the preparation of a medicament for the treatment of migraine
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL142581A (en) Medicament for treating heart disease
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
HUP0105203A2 (en) S-nitrosothiols as agents for the treatment of circulatory dysfunctions and their use
EE200200348A (en) A pharmaceutical composition for use in the treatment of pain
EP1244467A4 (en) Phosphoglycerate kinase in the treatment of disease
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof